Literature DB >> 391257

Modification of phenytoin clearance by valproic acid in normal subjects.

G M Frigo, S Lecchini, G Gatti, E Perucca, A Crema.   

Abstract

1 The effect of valproic acid on the distribution and elimination kinetics of intravenously administered phenytoin has been investigated in eight normal volunteers. 2 In each of the subjects studied the volume of distribution of phenytoin increased significantly during treatment with sodium valproate (1200 mg daily for 7 days). 3 Phenytoin clearance was markedly increased in presence of valproic acid as compared to control values (0.52 +/- 0.17 v 0.38 +/- 0.11 ml min-1 kg-1 respectively, P less than 0.02). 4 It is suggested that the increase of the volume of distribution and of the serum clearance are secondary to displacement of phenytoin from plasma protein binding sites by valproic acid.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391257      PMCID: PMC1429910          DOI: 10.1111/j.1365-2125.1979.tb01043.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Effect of sodium valproate on plasma protein binding of diphenylhydantoin.

Authors:  P N Patsalos; P T Lascelles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-06       Impact factor: 10.154

3.  Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.

Authors:  S Lecchini; G Gatti; M De Bernardi; M Caravaggi; G M Frigo; S Calzetti; D Visintini
Journal:  Farmaco Prat       Date:  1978-02

4.  The comparative enzyme-inducing properties of antiepileptic drugs [proceedings].

Authors:  E Perucca; A Hedges; K Makki; S Hebdige; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 5.  Drug therapy. Binding of drugs to serum albumin (second of two parts).

Authors:  J Koch-Weser; E M Sellers
Journal:  N Engl J Med       Date:  1976-03-04       Impact factor: 91.245

6.  Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding.

Authors:  M J Hayes; M J Langman; A H Short
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

7.  Valproic acid in epilepsy: clinical and pharmacological effects.

Authors:  R H Mattson; J A Cramer; P D Williamson; R A Novelly
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

Review 8.  Clinical pharmacokinetics of anticonvulsants.

Authors:  E F Hvidberg; M Dam
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors:  A Monks; S Boobis; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

10.  Determination of the anticonvulsant drug--dipropyl acetate (Epilim) in human plasma by gas chromatography.

Authors:  H U-Schulz; P A Toseland
Journal:  Ann Clin Biochem       Date:  1977-07       Impact factor: 2.057

View more
  7 in total

1.  Applying organ clearance concepts in a clinical setting.

Authors:  Jorge Duconge
Journal:  Am J Pharm Educ       Date:  2008-10-15       Impact factor: 2.047

2.  Interaction between valproic Acid and phenytoin.

Authors:  R G Closson
Journal:  West J Med       Date:  1983-01

3.  Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 6.  Drug interactions with valproic acid.

Authors:  R H Levy; K M Koch
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

7.  Valproic acid and diazepam interaction in vivo.

Authors:  S Dhillon; A Richens
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.